UBS Group’s CARGO Therapeutics CRGX Stock Holding History

UBS Group’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-79,110	Closed	-$326K	–	10396
2025 Q2	$326K	Buy	79,110 +25,334	+47%	+$109K	﹤0.01%	6375
2025 Q1	$219K	Sell	53,776 -112,598	-68%	-$754K	﹤0.01%	6489
2024 Q4	$2.4M	Buy	166,374 +134,194	+417%	+$2.44M	﹤0.01%	4556
2024 Q3	$594K	Buy	32,180 +4,404	+16%	+$78.8K	﹤0.01%	5090
2024 Q2	$456K	Sell	27,776 -18,799	-40%	-$357K	﹤0.01%	5068
2024 Q1	$1.04M	Buy	+46,575	New	+$1.11M	﹤0.01%	4567

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's CRGX Position: Q3 2025 in Review

UBS Group sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 79,110 shares — an estimated $326K sold.

UBS Group first reported a position in CRGX in Q1 2024 and held it in 6 quarters. The position peaked at $2.4M in Q4 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

UBS Group reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
UBS Group sold 79,110 CARGO Therapeutics shares in Q3 2025, an estimated $326K.
UBS Group first reported a position in CARGO Therapeutics in Q1 2024 and held it in 6 quarters.
UBS Group's CARGO Therapeutics position peaked at $2.4M in Q4 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.